MEDLENIK

This brand name is authorized in Japan.

Active ingredients

The drug MEDLENIK contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII U38V3ZVV3V - FERRIC CHLORIDE
 
Read more about Ferrous chloride
2
UNII QQE170PANO - MANGANESE CHLORIDE
 

Manganese is required for the synthesis of the mucopolysaccharides of cartilage, glucose utilisation, steroid biosynthesis and for the activity of pyruvate carboxylase. It is bound to arginase of the liver and activates many enzymes.

 
Read more about Manganese
3
UNII 89DS0H96TB - ZINC SULFATE, UNSPECIFIED FORM
 

Zinc sulfate is a source of zinc which is an essential trace element and involved in a number of body enzyme systems. Severe deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections and failure to thrive in children.

 
Read more about Zinc sulfate
4
UNII LRX7AJ16DT - CUPRIC SULFATE
 
Read more about Copper sulfate
5
UNII 1C4QK22F9J - POTASSIUM IODIDE
 

Potassium iodide is indicated as a thyroid-blocking agent to prevent the uptake of radioactive iodine, for example after a nuclear accident or during a nuclear medicine investigation before administering a radioiodinated compound, which is metabolised to iodide or which contains radioiodine impurities.

 
Read more about Potassium iodide

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
JP 医薬品医療機器総合機構 3229501A1060, 3229501G1046

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.